Skip to main content

Advertisement

Log in

New Italian guidelines for malaria prophylaxis in travellers to endemic areas

  • Guideline
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background and Methods

As a consequence of the rapid evolution of malaria prophylaxis recommendations throughout the world, the Italian Society of Tropical Medicine (SIMET—Società Italiana di Medicina Tropicale) has set up a working group in charge of preparing a new national guideline. Other scientific societies interested in the topic were also involved in the project.

Results and Conclusions

The group stated that awareness about malaria risk and characteristics, as well as protection from mosquito bites, are recommended for all travellers visiting malaria-endemic countries. The risk and benefit of malaria chemoprophylaxis must be carefully balanced before prescribing drugs: the disease-related risk must outweigh the possibility of drugs’ side effects. As a general rule, malaria pills are the first choice for travellers to high-risk areas, such as sub-Saharan Africa, Eastern India, Myanmar, Eastern Indonesia, Papua New Guinea and, with some limitations, South-East Asia, and the Amazon part of Venezuela, Guyana and French Guyana. However, several other factors, such as itinerary, season, duration of trip, availability of insect bite protection, pre-existing conditions and compliance, must be taken into account. In low-risk areas, stand-by emergency treatment is the first option. In minimal-risk areas and in Plasmodium vivax areas, a prompt diagnosis only is advised (Central America, South America outside the Amazon basin, Middle East, China, Thailand, Nepal). Recommendations may be modified when particular groups of travellers are concerned, such as long-term residents, visiting friends and relatives, patients with pre-existing conditions, pregnant women and children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization (WHO). International travel and health. 2012. http://www.who.int/ith/en/.

  2. Haut Conseil de la Santé Publique. Recommandations sanitaires pour les voyageurs, 2012 (à l’attention des professionnels de santé). Avis du 16 avril. BEH 20-21/29 mai 2012. http://www.sante.gouv.fr/IMG/pdf/Recommandations_sanitaires_pour_les_voyageurs_2012.pdf.

  3. Centers for Disease Control and Prevention (CDC). The yellow book 2012. Health information for international travel. Atlanta: CDC; 2012.

    Google Scholar 

  4. Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG). Empfehlungen zur Malariavorbeugung. 2012. http://www.dtg.org/uploads/media/Malaria_2012_01.pdf.

  5. Chiodini P, Hill D, Lalloo D, Lea G, Walker E, Whitty C, Bannister B. Guidelines for malaria prevention in travellers from the United Kingdom. London: Health Protection Agency; 2007.

    Google Scholar 

  6. Calleri G, Behrens RH, Bisoffi Z, Bjorkman A, Castelli F, Gascon J, Gobbi F, Grobusch MP, Jelinek T, Schmid ML, Niero M, Caramello P. Variability in malaria prophylaxis prescribing across Europe: a Delphi method analysis. J Travel Med. 2008;15:294–301. doi:10.1111/j.1708-8305.2008.00226.x.

    Article  PubMed  Google Scholar 

  7. Bisoffi Z, Napoletano G, Castelli F, Romi R. Linee guida per la profilassi antimalarica. Giorn Ital Med Trop. 2003;8:15–30.

    Google Scholar 

  8. Calleri G, Behrens RH, Schmid ML, Gobbi F, Grobusch MP, Castelli F, Gascon J, Bisoffi Z, Jelinek T, Caramello P; TropNetEurop. Malaria chemoprophylaxis recommendations for immigrants to Europe, visiting relatives and friends—a Delphi method study. Malar J. 2011;10;137. doi:10.1186/1475-2875-10-137.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Frickmann H, Schwarz NG, Holtherm HU, Maassen W, Vorderwülbecke F, Erkens K, Fischer M, Morwinsky T, Hagen RM. Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey. Infection. 2013;41:311–20. doi:10.1007/s15010-013-0411-5.

    Article  CAS  PubMed  Google Scholar 

  10. Behrens RH, Carroll B, Hellgren U, Visser LG, Siikamäki H, Vestergaard LS, Calleri G, Jänisch T, Myrvang B, Gascon J, Hatz C. The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator? Malar J. 2010;9:266. doi:10.1186/1475-2875-9-266.

    Article  PubMed Central  PubMed  Google Scholar 

  11. World Health Organization (WHO). Country profiles. http://www.who.int/malaria/publications/country-profiles/en/.

  12. World Health Organization (WHO). World malaria report. Geneva: WHO; 2012.

    Google Scholar 

  13. Rombo L. Who needs drug prophylaxis against malaria? My personal view. J Travel Med. 2005;12:217–21.

    Article  PubMed  Google Scholar 

  14. Petersen E. Malaria chemoprophylaxis: when should we use it and what are the options? Expert Rev Anti Infect Ther. 2004;2:119–32.

    Article  CAS  PubMed  Google Scholar 

  15. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297. doi:10.1186/1475-2875-10-297.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Dutto M, Severini F, Romi R. Guida per l’entomoprofilassi. Rapporti ISTISAN 11/24. 2011. http://www.iss.it/binary/publ/cont/11_24_web.pdf.

  17. Franco-Paredes C, Santos-Preciado JI. Problem pathogens: prevention of malaria in travellers. Lancet Infect Dis. 2006;6:139–49.

    Article  CAS  PubMed  Google Scholar 

  18. Schwartz E. Prophylaxis of malaria. Mediterr J Hematol Infect Dis. 2012;4:e2012045. doi:10.4084/MJHID.2012.45.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Jacquerioz FA, Croft AM. Drugs for preventing malaria in travellers. Cochrane Database Syst Rev. 2009;(4):CD006491.

  20. Genton B, D’Acremont V. Malaria prevention in travelers. Infect Dis Clin North Am. 2012;26:637–54. doi:10.1016/j.idc.2012.05.003.

    Article  PubMed  Google Scholar 

  21. Askling HH, Bruneel F, Burchard G, Castelli F, Chiodini PL, Grobusch MP, Lopez-Vélez R, Paul M, Petersen E, Popescu C, Ramharter M, Schlagenhauf P; European Society for Clinical Microbiology and Infectious Diseases Study Group on Clinical Parasitology. Management of imported malaria in Europe. Malar J. 2012;11:328. doi:10.1186/1475-2875-11-328.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011;10:378.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Ramharter M, Grobusch MP, Kiessling G, Adegnika AA, Möller U, Agnandji ST, Kramer M, Schwarz N, Kun JF, Oyakhirome S, Issifou S, Borrmann S, Lell B, Mordmüller B, Kremsner PG. Clinical and parasitological characteristics of puerperal malaria. J Infect Dis. 2005;191:1005–9.

    Article  PubMed  Google Scholar 

  24. McGready R, Ashley EA, Nosten F. Malaria and the pregnant traveller. Travel Med Infect Dis. 2004;2:127–42.

    Article  CAS  PubMed  Google Scholar 

  25. Royal College of Obstetricians and Gynaecologists. The prevention of malaria in pregnancy. Green-top guideline no. 54A. 2010. http://www.rcog.org.uk/files/rcog-corp/GTG54aPreventionMalariaPregnancy0410.pdf.

  26. Schlagenhauf P, Blumentals WA, Suter P, Regep L, Vital-Durand G, Schaerer MT, Boutros MS, Rhein HG, Adamcova M. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy. Clin Infect Dis. 2012;54:e124–31.

    Article  CAS  PubMed  Google Scholar 

  27. Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev. 2008;21:466–72.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Matteelli A, Carvalho AC, Bigoni S. Visiting relatives and friends (VFR), pregnant, and other vulnerable travelers. Infect Dis Clin North Am. 2012;26:625–35.

    Article  PubMed  Google Scholar 

  29. Steffen R, Heusser R, Mächler R, Bruppacher R, Naef U, Chen D, Hofmann AM, Somaini B. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull World Health Organ. 1990;68:313–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Romi R, Boccolini D, D’Amato S, Cenci C, Peragallo M, D’Ancona F, Pompa MG, Majori G. Incidence of malaria and risk factors in Italian travelers to malaria endemic countries. Travel Med Infect Dis. 2010;8:144–54. doi:10.1016/j.tmaid.2010.02.001.

    Article  PubMed  Google Scholar 

  31. Mascarello M, Gobbi F, Angheben A, Concia E, Marocco S, Anselmi M, Monteiro G, Rossanese A, Bisoffi Z. Imported malaria in immigrants to Italy: a changing pattern observed in north eastern Italy. J Travel Med. 2009;16:317–21.

    Article  PubMed  Google Scholar 

  32. Scolari C, Tedoldi S, Casalini C, Scarcella C, Matteelli A, Casari S, El Hamad I, Castelli F. Knowledge, attitudes, and practices on malaria preventive measures of migrants attending a public health clinic in northern Italy. J Travel Med. 2002;9:160–2.

    Article  PubMed  Google Scholar 

  33. Joint Formulary Committee. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2006.

  34. Castelli F, Patroni A. The human immunodeficiency virus-infected traveler. Clin Infect Dis. 2000;31:1403–8.

    Article  CAS  PubMed  Google Scholar 

  35. World Health Organization (WHO). Standards for maternal and neonatal care. Geneva: WHO; 2004.

    Google Scholar 

  36. Abecasis J, Dores H, Arroja I, Santos JM, Silva A. Travelers on beta-blockers: is malaria chemoprophylaxis dangerous? Rev Port Cardiol. 2009;28:1153–9.

    PubMed  Google Scholar 

  37. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64:28–35.

    CAS  PubMed  Google Scholar 

  38. Descloux E, De Monbrison F, Basselin C, Vial T, Peyron F. Mefloquine adverse effects with atypical facial lesions in an overweight patient. Travel Med Infect Dis. 2010;8:318–21.

    Article  PubMed  Google Scholar 

  39. Nayyar GML, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488–96. doi:10.1016/S1473-3099(12)70064-6.

    Article  PubMed  Google Scholar 

  40. World Health Organization (WHO). Guidelines for the treatment of malaria. Second edition. Geneva: WHO; 2010. http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html.

Download references

Conflict of interest

GC has received grants for speaking by Sigma-Tau; FC has acted as PI for a Sigma-Tau-sponsored trial; IEH, FG, AM, GN, RR, and AR declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Calleri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calleri, G., Castelli, F., El Hamad, I. et al. New Italian guidelines for malaria prophylaxis in travellers to endemic areas. Infection 42, 239–250 (2014). https://doi.org/10.1007/s15010-013-0563-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0563-3

Keywords

Navigation